Literature DB >> 5902055

Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.

G B Arden, H Kolb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5902055      PMCID： PMC1843522          DOI： 10.1136/bmj.1.5482.270

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  15 in total

1.  CHLOROQUINE RETINOPATHY AND ITS INCIDENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS.

Authors: 
Journal:  Acta Rheumatol Scand       Date:  1964

2.  Ocular abnormalities in patients treated with synthetic antimalarial drugs.

Authors:  P HENKIND; N F ROTHFIELD
Journal:  N Engl J Med       Date:  1963-08-29       Impact factor: 91.245

3.  EARLY CHLOROQUINE RETINOPATHY: CLINICAL AND FUNCTIONAL FINDINGS.

Authors:  P HENKIND; R E CARR; I M SIEGEL
Journal:  Arch Ophthalmol       Date:  1964-02

4.  EXPERIMENTAL INVESTIGATION OF THE MORPHOGENESIS OF CHLOROQUINE RETINOPATHY.

Authors:  W MEIER-RUGE
Journal:  Arch Ophthalmol       Date:  1965-04

5.  [RETINOPATHY CAUSED BY THE USE OF CHLOROQUINE AND RELATED DRUGS].

Authors:  I BUTLER
Journal:  Ned Tijdschr Geneeskd       Date:  1965-04-03

6.  Anticipation of chloroquine retinopathy.

Authors:  G B ARDEN; A FRIEDMANN; H KOLB
Journal:  Lancet       Date:  1962-06-02       Impact factor: 79.321

7.  Electrophysiological abnormalities in pigmentary degenerations of the retina. Assessment of value and basis.

Authors:  G B ARDEN; M R FOJAS
Journal:  Arch Ophthalmol       Date:  1962-09

8.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

9.  Unusual ocular lesions in a case of systemic lupus erythematosus.

Authors:  A CAMBIAGGI
Journal:  AMA Arch Ophthalmol       Date:  1957-03

10.  OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

Authors:  H E Hobbs; S P Eadie; F Somerville
Journal:  Br J Ophthalmol       Date:  1961-04       Impact factor: 4.638
View more
  8 in total

1.  Chloroquine toxicity due to long-term Elestol for osteoarthrosis.

Authors:  A K Clarke; R L Meyrick
Journal:  Br Med J       Date:  1977-09-10

Review 2.  Rheumatoid arthritis. Surgical treatment.

Authors:  G P Arden; S H Harrison; B M Ansell
Journal:  Br Med J       Date:  1970-12-05

Review 3.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

4.  Delayed chloroquine retinopathy.

Authors: 
Journal:  Br Med J       Date:  1967-02-04

5.  Chloroquine retinopathy: is there a safe daily dose?

Authors:  J S Marks
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

6.  Screening for antimalarial maculopathy in rheumatology clinics.

Authors:  B W Fleck; A L Bell; J D Mitchell; B J Thomson; N P Hurst; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

7.  Ultrastructural alterations in rat and cat retina and pigment epithelium induced by chloroquine.

Authors:  T A Ivanina; M V Zueva; M N Lebedeva; A I Bogoslovsky; A J Bunin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

8.  An audit of the use of hydroxychloroquine in rheumatology clinics.

Authors:  Claudia Worth; Imran H Yusuf; Bethany Turner; Hanae Gourier; Emma E Brooks; Daniel O Mort; Srilakshmi Sharma; Susan M Downes; Raashid A Luqmani
Journal:  Rheumatol Adv Pract       Date:  2018-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.